Veracyte, Inc. Veracyte, Inc.

Veracyte, Inc.

VCYT

Rang în acțiuni #4352
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Preț acțiune
$45.39
Capitalizare de piață
$3.65B
Schimbare (1 zi)
1.34%
Schimbare (1 an)
25.73%
Țară
US
Tranzacționează Veracyte, Inc. (VCYT)

Categorie

Healthcare
Venituri pentru Veracyte, Inc. (VCYT)
Venituri în Jun 2026 TTM: $561.90M
Conform celor mai recente rapoarte financiare ale Veracyte, Inc., venitul actual al companiei (TTM) este $561.90M. În anul 2023, compania a avut un venit de $361.05M o creștere față de venitul din anul 2022, care a fost de $296.54M. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Veracyte, Inc. din 2011 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
2026 (TTM) $561.90M 26.05%
2024 $445.76M 23.46%
2023 $361.05M 21.76%
2022 $296.54M 35.09%
2021 $219.51M 86.85%
2020 $117.48M -2.40%
2019 $120.37M 30.82%
2018 $92.01M 27.87%
2017 $71.95M 10.55%
2016 $65.09M 31.48%
2015 $49.50M 29.62%
2014 $38.19M 74.51%
2013 $21.88M 88.20%
2012 $11.63M 339.62%
2011 $2.65M 0.00%
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
$46.34B 8,146.31%
US
$25.11B 4,368.23%
US
$2.71B 381.77%
US
- -
CN
$7.37B 1,211.98%
US